All In MedTech

Device Trial Radar · NCT05106491

Safety and Efficacy of Synchronized Cardiac Support (SCS) Versus Continuous Flow VA-ECMO in Cardiogenic Shock

Safety and Efficacy of Synchronized Cardiac Support (SCS) Versus Continuous Flow VA-ECMO in Cardiogenic Shock: A Randomized-Controlled Pilot Study

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Jan 2027

Primary completion

Jan 2029

Study completion Mar 2029

Sponsor

Lead sponsor
Xenios AGNot on our public-company list
Sponsor type
Industry
Collaborators
IHF GmbH - Institut für Herzinfarktforschung
First posted
Nov 3, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to investigate the efficacy of the Synchronized Cardiac Support treatment with the Novalung ultimate kit SCS in patients with cardiogenic shock in comparison with patients treated with continuous flow VA-ECMO

Conditions

  • Cardiogenic Shock
  • Extracorporeal Membrane Oxygenation
  • ECLS
  • VA ECMO

Interventions

  • Synchronized Cardiac Support with the Novalung ultimate kit SCSDevice

    Patients receiving Synchronized Cardiac Support (SCS) treatment with the Novalung ultimate kit SCS and the Xenios 2.0 - Pulsatile flow

  • Control group: VA-ECMODevice

    Patients receiving continuous flow VA-ECMO with the Novalung ultimate kit SCS and the Xenios 2.0 (Standard of care)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cardiocirculatory stabilization and end-organ perfusionTime frame: Baseline and during the ECMO treatment up to 7 days

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • General University Hospital Prague

    Prague, Czechia

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.